Frontal Fibrosing Alopecia: A Review
Metadatos
Mostrar el registro completo del ítemAutor
Porriño Bustamante, María Librada; Fernández Pugnaire, María Antonia; Arias Santiago, Salvador AntonioEditorial
MDPI
Materia
Frontal fibrosing alopecia Scarring alopecia Bulge Trichoscopy Histopathology Treatment
Fecha
2021-04-21Referencia bibliográfica
Porriño-Bustamante, M.L.; Fernández-Pugnaire, M.A.; Arias-Santiago, S. Frontal Fibrosing Alopecia: A Review. J. Clin. Med. 2021, 10, 1805. [https://doi.org/10.3390/jcm10091805]
Resumen
Frontal fibrosing alopecia is a scarring alopecia, the prevalence of which is increasing worldwide since its first description in 1994. The reason for this emerging epidemic may be a higher exposure to an unknown trigger, although its aethiology and pathogenesis still remain enigmatic. Clinical, trichoscopic, sonographic, and histopathologic findings are allowing clinicians to understand more aspects about this type of cicatricial alopecia. Several treatments have been used in frontal fibrosing alopecia, although the 5-alpha reductase inhibitors seem to be the most promising. The aim of this report is to provide a compilation about the published data regarding frontal fibrosing alopecia in a narrative review.